Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Dr. Walensky has […]
HIV
To control the global health threat of HIV by 2030, according to UNAIDS, these goals must be reached by 2020: To diagnose 90 percent of all […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With more than 112,000 cases of measles reported by 170 countries so far this year, the world is seeing rising rates of a vaccine-preventable illness over […]